Medicinal mushroom science: Current perspectives, advances, evidences, and challenges

Biomedical Journal

Volumn 37, Issue 6, 2014, Pages 345-356

  Wasser, Solomon P ^a,b  

^a UNIVERSITY OF HAIFA   (Israel)

^b INSTITUTE OF HYDROBIOLOGY   (Ukraine)

Author keywords

antioxidant activities; antitumor; immunomodulating; medicinal mushrooms; polysaccharides; secondary metabolites; glucans

Indexed keywords

ALKALOID DERIVATIVE; AMLODIPINE BESYLATE; AMYLOBAN; ANTIBIOTIC AGENT; ATORVASTATIN; BETA GLUCAN; BEVACIZUMAB; CAFFEIC ACID PHENETHYL ESTER; CETUXIMAB; CORDYCEPIN; FUNGAL POLYSACCHARIDE; GLUCOSE OXIDASE; GLUCURONOXYLOMANNAN; HERICENONE; KRESTIN; LACCASE; LACTONE DERIVATIVE; LENTINAN; MONOPHENOL MONOOXYGENASE; NATURAL PRODUCT; PANEPOXYDONE; PEROXIDASE; PROBIOTIC AGENT; PROTEIN DERIVATIVE; SCHIZOPHYLLAN; SUPEROXIDE DISMUTASE; TAMOXIFEN; TRASTUZUMAB; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTINEOPLASTIC AGENT; ANTIOXIDANT; POLYSACCHARIDE;

ACUTE HEPATITIS; ANTIBACTERIAL ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIHYPERCHOLESTEROLEMIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPARASITIC ACTIVITY; ANTIVIRAL ACTIVITY; BASIDIOMYCETES; BREAST CANCER; CANCER INHIBITION; CARDIOVASCULAR EFFECT; CELLULAR IMMUNITY; COMA; DRUG ACTIVITY; DRUG DETOXIFICATION; FEVER; HETEROBASIDIOMYCETES; HOMOBASIDIOMYCETES; HUMAN; IMMUNOMODULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; KIDNEY DISEASE; LIVER PROTECTION; MEDICINAL MUSHROOM; METASTASIS INHIBITION; MYCELIUM; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PROTEIN SYNTHESIS INHIBITION; RADICAL SCAVENGING; REVIEW; AGARICALES; ANIMAL; METABOLISM; NEOPLASMS;

AGARICALES; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BASIDIOMYCOTA; HUMANS; NEOPLASMS; POLYSACCHARIDES;

EID: 84920095146     PISSN: 23194170     EISSN: None     Source Type: Journal    
DOI: 10.4103/2319-4170.138318     Document Type: Review

References (85)

1. Reshetnikov SV, Wasser SP, Tan KK. Higher Basidiomycota as source of antitumor and immunostimulating polysaccharides. Int J Med Mushrooms 2001;3:361-94.
2. Van Griensven LJ. Culinary-medicinal mushrooms: Must action be taken. Int J Med Mushrooms 2009;11:281-6.
3. Wasser SP. Medicinal mushroom science: History, current status, future trends, and unsolved problems. Int J Med Mushrooms 2010;12:1-16.
4. Chang ST, Wasser SP. The role of culinary-medicinal mushrooms on human welfare with a pyramid model for human health. Int J Med Mushrooms 2012;1:95-134.
5. Pöder R. The Ice man's fungi: Facts and mysteries. Int J Med Mushrooms 2005;7:357-9.
6. Wasson RG. Soma. Divine mushroom of immortality. NY, USA: Harcourt Brace Jovanovich, Inc.; 1968.
7. Hyde KD, Bahkali AH, Moslem MA. Fungi-an unusual source for cosmetics. Fungal Divers 2010;43:1-9.
8. Lindequist U. The merit of medicinal mushrooms from a pharmaceutical point of view. Int J Med Mushrooms 2013;15:517-23.
9. Hawksworth DL. Mushrooms: The extent of the unexplored potential. Int J Med Mushrooms 2001;3:333-40.
10. Hawksworth DL. Global species number of fungi: Are tropical studies and molecular approaches contributing to a more robust estimate? Biodivers Conserv 2012;21:2425-33.
11. th ed. Wallingford: CAB International; 2008.
12. Blackwell M. The fungi: 1, 2, 3 ⋯ 5.1 million species? Am J Bot 2011;98:426-38.
13. Bass D, Richards TA. Three reasons to re-evaluate fungal diversity 'on Earth and in the ocean'. Fungal Biol Rev 2011;25:159-64.
14. Hibbett DS, Taylor JW. Fungal systematics: Is a new age of enlightenment at hand? Nat Rev Microbiol 2013;11:129-33.
15. Anke T. Basidiomycetes: A source for new bioactive secondary metabolites. Prog Ind Microbiol 1989;27:51-66.
16. Zaidman BZ, Yassin M, Mahajna J, Wasser SP. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol 2005;67:453-68.
17. De Silva DD, Rapior S, Sudarman E, Stadler M, Xu J, Alias SA, et al. Bioactive metabolites from macrofungi: Ethnopharmacology, biological activities and chemistry. Fungal Divers 2013;62:1-40.
18. Dai YC, Yang ZL, Ui BK, Yu CH, Zhou LW. Species diversity and utilization of medicinal mushrooms and fungi in China (review). Int J Med Mushrooms 2009;11:287-302.
19. Lo HC, Wasser SP. Medicinal mushrooms for glycemic control in diabetes mellitus: History, current status, future perspectives, and unsolved problems (review). Int J Med Mushrooms 2011;13:401-26.
20. Didukh MY, Wasser SP, Nevo E. Medicinal value of species of the family Agaricaceae Cohn (higher Basidiomycetes) current stage of knowledge and future perspectives. Int J Med Mushrooms 2003;5:133-52.
21. Chihara G, Hamuia J, Maeda YY, Arai Y, Fukuoka F. Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (Berk.) Sing. (an edible mushroom). Cancer Res 1970;30:2776-81.
22. Zhang M, Cui SW, Cheung PC, Wang Q. Antitumor polysaccharides from mushrooms: A review on their isolation process, structural characteristics and antitumor activity. Trends Food Sci Technol 2007;18:4-19.
23. Zhang Y, Li S, Wang X, Zhang L, Cheung PC. Advances in lentinan: Isolation, structure, chain conformation and bioactivities. Food Hydrocoll 2011;25:1996-2006.
24. Zhang Y, Kong H, Fang Y, Nishinan K, Phillips GO. Schizophyllan: A review on its structure, properties, bioactivities and recent development. Bioact Carbohydr Diet Fiber 2013;1:53-71.
25. Lee DH, Kim HW. Innate immunity induced by fungal b-glucans via dectin-1 signaling pathway. Int J Med Mushrooms 2014;16:1-16.
26. Barillot E, Calzone L, Hupe Ph, Vert JPH, Zinovyev A. Computation system biology of cancer. USA: CRC Press, Taylor and Francis Group. A Chapman and Hall Book; 2013.
27. Stewart BW, Wild CHP, editors. World Cancer Report 2014. Lyon, France: International Agency for Research on Cancer; 2014.
28. Mizuno T. The extraction and development of antitumor-active polysaccharides from medicinal mushrooms in Japan (Review). Int J Med Mushrooms 1999;1:9-29.
29. Hobbs C. Medicinal value of Lentinus edodes (Berk.) Sing. (Agaricomycetideae). A literature review. Int J Med Mushrooms 2000;2:287-302.
30. Zhuang C, Wasser SP. Medicinal value of culinary-medicinal Maitake mushroom Grifola frondosa (Dicks.:Fr.) S.F. Gray (Aphyllophoromycetideae). Review. Int J Med Mushrooms 2004;6:287-313.
31. Boh B, Berivic M. Grifola frondosa (Diks.:Fr.) S.F. Gray (Maitake mushroom): Medicinal properties, active compounds, and biotechnological cultivation. Int J Med Mushrooms 2007;9:89-108.
32. Hobbs C. The chemistry, nutritional value, immunopharmacology, and safety of the traditional food of medicinal split-gill fungus Schizophyllum commune Fr.:Fr. (Aphyllophoromycetideae). A literature review. Int J Med Mushrooms 2005;7:127-40.
33. Lin ZB. Lingzhi. From mystery to science. Beijing, China: Peking University Press; 2009.
34. Mahajna J, Dotan N, Zaidman BZ, Petrova RD, Wasser SP. Pharmacological values of medicinal mushrooms for prostate cancer therapy: The case of Ganoderma lucidum. Nutr Cancer 2010;61:16-26.
35. Hobbs C. Medicinal value of Turkey Tail fungus Trametes versicolor (L.:Fr.) Pilát (Aphyllophoromycetideae). Int J Med Mushrooms 2004;6:195-218.
36. Mizuno T, Zhuang C, Abe K, Okamoto H, Kiho T, Ukai S, et al. Antitumor and hypoglycemic activities of polysaccharides from the sclerotia and mycelia of Inonotus obliquus (Pers.:Fr.) Pil. (Aphyllophoromycetideae). Int J Med Mushrooms 1999;1:301-16.
37. Balandykin ME, Zmitrovich IV. Review on Inonotus obliquus (Basidiomycota). Realm on medicinal applications and approaches on resources estimation. Int J Med Mushrooms 2014;16 (In Press).
38. Hsieh PW, Wu JB, Wu YC. Chemistry and biology of Phellinus linteus. BioMed 2013;3:106-13.
39. Maruyama H, Ikekawa T. Immunomodulation and antitumor activity of a mushroom product, proflamin, isolated from Flammulina velutipes (W. Curt.:Fr.) Singer (Agaricomycetideae). Int J Med Mushrooms 2007;9:109-22.
40. Matsuzawa T. Studies on antioxidant effects of culinary-medicinal bunashimeji mushroom Hypsizygus marmoreus (Peck) Bigel. (Agaricomycetidae). Int J Med Mushrooms 2006;8:245-50.
41. Holliday H, Cleaver M. Medicinal value of the caterpillar fungi species of the genus Cordyceps (Fr.) Link (Ascomycetes). A review. Int J Med Mushrooms 2008;10:209-18.
42. Wasser SP, Didukh MY, Amazonas MA, Nevo E, Stamets P, Eira AF. Is widely cultivated culinary-medicinal Royal Sun Agaricus (the Himematsutake mushroom) indeed Agaricus blazei Murrill? Int J Med Mushrooms 2002;4:267-90.
43. Wasser SP, Didukh MY, Amazonas MA, Nevo E, Stamets P, Eira AF. Is a widely cultivated culinary-medicinal Royal Sun Agaricus (Champignon do Brazil, or the Himematsutake mushroom) Agaricus brasiliensis S. Wasser et al. indeed a synonym of A. subrufescens Peck? Int J Med Mushrooms 2005;7:507-11.
44. Lachter J, Yampolsky Y, Gafni-Schieber R, Wasser SP. Yellow Brain Culinary-Medicinal Mushroom, Tremella mesenterica Ritz.:Fr. (Higher Basidiomycetes), is subjectively but not objectively effective for eradication of Helicobacter pylori; a prospective controlled trial. Int J Med Mushrooms 2012;14:55-63.
45. Yassin M, Wasser SP, Mahajna J, Ruimi N, Denchev CM, Sussan S, et al. Substances from the medicinal mushroom Daedalea gibbosa inhibit kinase activity of native and T315I mutated Bcr-Abl. Int J Oncol 2008;32:1197-204.
46. Petrova RD, Mahajna J, Wasser SP, Ruimi N, Denchev CM, Sussan S, et al. Marasmius oreades substances block NF-kappaB activity through interference with IKK activation pathway. Mol Biol Rep 2009;36:737-44.
47. Rouhana-Toubi A, Wasser SP, Fares F. Ethyl acetate extracts of submerged cultured mycelium of higher Basidiomycetes mushrooms inhibit human ovarian cancer cell growth. Int J Med Mushrooms 2009;11:29-37.
48. Dotan N, Wasser SP, Mahajna J. The culinary-medicinal mushroom Coprinus comatus as a natural antiandrogenic modulator. Integr Cancer Ther 2011;10:148-59.
49. Ruimi N, Petrova RD, Agbaria R, Sussan S, Wasser SP, Reznick AZ, et al. Inhibition of TNFα-induced iNOS expression in HSV-tk transduced 9L glioblastoma cell lines by Marasmius oreades substances through NF-κB- and MAPK-dependent mechanisms. Mol Biol Rep 2010;37:3801-12.
50. Ruimi N, Rwashdeh H, Wasser SP, Konkimalia B, Efferth T, Borgatti M, et al. Daedalea gibbosa substances inhibit LPS-induced expression of iNOS by suppression of NF-κB and MAPK activities in RAW 264.7 macrophage cells. Int J Mol Med 2010;25:421-32.
51. Boh B. Ganoderma lucidum: A potential for biotechnological production of anti-cancer and immunomodulatory drugs. Recent Pat Anticancer Drug Discov 2013;8:255-87.
52. Wasser SP, Zmitrovich IV, Didukh MY, Spirin WA, Malysheva VF. Morphologigal traits of Ganoderma lucidum complex highlighting G. tsugae var. jannieae: The current generalization. Ruggell, Liechtenstein: A.R.A. Gantner Verlag K.-G.; 2006.
53. Moncalvo JM, Rivarden L. A nomenclatural study of the Ganodermataeae. Fungiflora A/S Oslo:; Norway, 1997.
54. Zhao JD. The Ganodermataceae of China. Bibliotheca Mycologica 132. Gebru{double grave}der Borntraeger, Berlin, Stuttgart: 1989.
55. Cao Y, Wu SH, Dai YC. Species clarification of the prize medicinal Ganoderma mushroom "Lingzhi". Fungal Divers 2012;56:49-62.
56. Yang ZL, Feng B. What is the Chinese "Lingzhi"? - a taxonomic mini-review. Mycology 2013;4:1-4.
57. Chen Sh, Xu J, Liu C, Zhu Y, Nelson DR, Zhou S, et al. Genome sequence of the model medicinal mushroom Ganoderma lucidum. Nature communications 2012;3:913.
58. Kerrigan RW. Agaricus subrufescens, a cultivated edible and medicinal mushroom, and its synonyms. Mycologia 2005;97:12-24.
59. Wasser SP. Molecular identification of species of the genus Agaricus. Why should we look at morpholgy? Int J Med Mushrooms 2007;9:85-8.
60. Buchalo AS, Mykchaylova O, Lomberg M, Wasser SP. Microstructures of vegetative mycelium of macromycetes in pure culture. Kiev, Ukraine; Alter Press; 2009.
61. nd ed. NY, London, Oxford: The Haworth Herbal Press; 2002.
62. Deng G, Lim H, Seidman A, Fornier M, D'Andrea G, Wesa K, et al. A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: Immunological effects. J Cancer Res Clin Oncol 2009;135:1215-21.
63. Ishibashi KI, Dogasaki C, Iriki T, Motoi M, Kurone YI, Miura NN, et al. Anti-β-glucan antibody in bovine sera. Int J Med Mushrooms 2005;7:513.
64. Li JW, Vederas JC. Drug discovery and natural products: End of an era or an endless frontier. Science 2009;325:161-5.
65. Ammerpohl O, Tiwari S, Kalthoff H. Target gene discovery for novel therapeutic agents in cancer treatment. Methods Mol Biol 2010;576:427-45.
66. Pollack A. Drug firms see fortune in treating cancer. Int Herald Tribune 2009; 15-16.
67. Endo A. The origin of the statins. 2004. Atheroscler Suppl 2004;5:125-30.
68. Chen J, Seviour R. Medicinal importance of fungal β-(1-3), (1-6)-glucans. Mycol Res 2007;111:635-52.
69. Ohno N. Structural diversity and physiological functions Of β-glucans. Int J Med Mushrooms 2005;7:167-73.
70. Miller H, Zhang J, Kuo Lee R, Patel GB, Chen W. Intestinal M cells: The fallible sentinels? World J Gastroenterol 2007;14:1477-86.
71. Pamer EG. Immune responses to commensal and environmental microbes. Nat Immunol 2007;8:1173-8.
72. Lehmann J, Kunze R. Water-soluble low molecular weight beta-glucans for modulating immunological responses in mammalian system. US Patent 2000; 6143883.
73. Tada R, Adachi Y, Ishibashi KI, Tsubaki K, Ohno N. Binding capacity of a barley beta-D-glucan to the beta-glucan recognition molecule Dectin-1. J Agric Food Chem 208;56:1442-50.
74. Tiwari U, Cummins E. Factors influencing beta-glucan levels and molecular weight in cereal-based products. Cereal Chem 2009;86:290-301.
75. Liu JJ, Gunn L, Hansen R, Yan J. Combined yeast-derived beta glucan with anti-tumor monoclonal antibody for cancer immunotherapy. Exper Mol Pathol 2009;86:208-14.
76. Taylor PR, Tsoni SV, Willment JA, Dennehy KM, Rosas M, Findon H, et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol 2007;8:31-8.
77. Harada T, Ohno N. Dectin-1 and GM-CSF on immunomodulating activities of fungal 6-branched 1,3-ß-glucans. Int J Med Mushrooms 2008;10:101-14.
78. Graham LM, Brown GD. The Dectin-2 family of C-type lectins in immunity and homeostasis. Cytokine 2009;48:148-55.
79. Falch BH, Espevik T, Ryan L, Stokke BT. The cytokine stimulating activity of (1-3)-beta-D-glucans is dependent on the triple helix conformation. Carbohydr Res 2000;329:587-96.
80. Park HG, Shim YY, Choi SO, Park WM. New method development for nanoparticle extraction of water-soluble β-(1-3)-D-glucan from edible mushrooms, Sparassis crispa and Phellinus linteus. J Agric Food Chem 2009;57:2147-54.
81. Nitschke J, Modick H, Busch E, von Rekowski RW, Albenbach HJ, Mölleken H. A new colorimetric method to quantify b-1,3-1,6-glucans in comparison with total β-1,3-glucans in edible mushrooms. Food Chem 2011;127:791-6.
82. Khamaisie H, Sussan S, Tal M, Najajren Y, Rurhardt M, Mahajna J. Oleic acid is the active component in the mushroom Daedalea gibbosa inhibiting Bcr-Abl kinase autophosphorylation activity. Anticancer Res 2011;31:177-4.
83. Sharvit LE, Wasser SP, Fares F. The effect of culture liquid ethyl acetate mycelium extracts of medicinal mushrooms on the viability of human pancreatic cancer cells. Int J Med Mushrooms 2012;14:169-80.
84. Roberts RM, Smith GW, Bazer FW, Cibelli J, Seidel GE Jr, Bauman DE, et al. Research priorities. Farm animal research in crisis. Science 2009;324:468-9.
85. Jong SC. Protecting intellectual property assest of mushroom genetic resources for invention and innovation. Int J Med Mushrooms 2005;7:348-9.